Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  Breaking News: FDA Approves Triumeq, New Once-Daily Combination Pill
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

HIV Vaccine Trial Participation Might Lead to Negative Social Consequences, Study Says

December 3, 2007

HIV vaccine trial volunteers could experience negative social consequences because of their participation in the trials, according to a study published in the Nov. 1 issue of the Journal of Acquired Immune Deficiency Syndromes, Reuters Health reports.

For the study, Jonathan Fuchs of the San Francisco Department of Public Health and colleagues evaluated the negative social effects reported by 5,417 people who participated in HIV vaccine clinical trials. Nearly 1,000 volunteers reported negative social events -- including negative reactions from friends, family and partners -- during a 36-month follow-up period, the study found. The study authors attributed the negative reaction to a misunderstanding of the volunteers' HIV status or risk of contracting the virus, Reuters Health reports.

Less than 1% of the participants reported problems with disability or life insurance, employment, medical or dental care, insurance, government agencies or housing, according to the study. The study also found that 12 of the 368 participants who contracted HIV after the trial reported at least one negative social event, mostly involving family or friends who believed the experimental vaccine caused the trial participant to become HIV-positive or more susceptible to the virus. Twenty-nine volunteers reported negative social events related to HIV antibodies, although the researchers attributed the events to vaccine-induced antibody results.

Advertisement
Fuchs said that health care providers should ask whether patients "have participated in an HIV vaccine trial before they perform HIV testing, to avoid potential misinterpretation of antibody results and possible social harm." In an effort to minimize negative social effects, the researchers recommended that trial sites "continue their educational efforts with both study participants and with local communities" and emphasize that people cannot contract HIV "from the vaccine itself and that these trials seek HIV-negative individuals" (Boggs, Reuters Health, 11/29).

Online An abstract of the study is available online.

Back to other news for December 2007


Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2007 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
More HIV News

Tools
 

Advertisement